Search results
Regeneron touts success with bispecific antibody in multiple myeloma trial
Clinical Trials Arena via Yahoo Finance· 9 hours agoRegeneron has released encouraging trial results for its multiple myeloma antibody, linvoseltamab....
Anti-Ro/SSA Antibodies Have Potential to Predict ILD in SSc
Medscape· 4 days agoAnti-Ro/SSA antibodies may help predict which patients with systemic sclerosis (SSc) are at a...
US FDA puts partial clinical hold on BioNTech's early-stage study of cancer drug
Reuters via AOL· 12 hours agoThe drug, an antibody-drug conjugate (ADC), was being studied in a trial sponsored by China-based...
Invivyd reports antibody neutralization of new COVID variants By Investing.com
Investing.com· 3 days agoInvivyd, Inc. (NASDAQ:IVVD), a biopharmaceutical company, announced today that its investigational...
Scientists engineer human antibodies that could neutralize black widow toxin
Medical Xpress· 6 days agoThere are various types of widow spiders, including black, red, and brown varieties in North and...
Mouse study suggests cancer drug could be used to target protein connection that spurs Parkinson's...
Medical Xpress· 8 hours agoThe findings, published May 31 in Nature Communications, reveal how Aplp1 connects with Lag3, another cell surface receptor, in a key part of a process that helps spread harmful alpha-synuclein ...
Biotest wins FDA approval for plasma protein therapy
Pharmaceutical Technology via Yahoo Finance· 9 hours agoYimmugo is an intravenous immunoglobulin therapy developed as a substitution therapy for primary antibody deficiency syndromes. The Barcelona,...
Johnson & Johnson’s nipocalimab shows promise in Sjögren’s disease trial
Clinical Trials Arena via Yahoo Finance· 14 hours agoJohnson & Johnson announced findings from the Phase II DAHLIAS dose-ranging study where its...
What causes long COVID? Case builds for rogue antibodies
Nature· 5 days agoStudy finds that antibodies from people with the debilitating condition trigger similar symptoms in...
Pfizer reports data from Phase II multiple myeloma treatment trial
Clinical Trials Arena via Yahoo Finance· 16 hours agoELREXFIO is a B-cell maturation antigen (BCMA)-cluster of differentiation (CD)3-directed bispecific ...